Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Motor Activity 6 Neoplasms 4 Breast Neoplasms 4 Multiple Myeloma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Warts 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Lymphoma 1 Insulin Resistance 1 Hematologic Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1 Carcinoma, Hepatocellular 1 Brenner Tumor 1 Bone Metastases 1 Body Weight 1

Interventions

Rituximab 134 Cyclophosphamide 126 Etoposide 58 fludarabine phosphate 55 Vincristine 55 Doxorubicin 53 Prednisone 49 Filgrastim 45 Methotrexate 42 Melphalan 41 Cytarabine 41 fludarabine 39 Busulfan 38 Whole-Body Irradiation 34 Tacrolimus 31 Mycophenolic Acid 30 Granulocyte Colony-Stimulating Factor 29 Radiotherapy 25 Antilymphocyte Serum 25 Peripheral Blood Stem Cell Transplantation 21 Dexamethasone 20 Carmustine 20 Lenalidomide 19 Stem Cell Transplantation 18 Bortezomib 18 Gemcitabine 16 Cyclosporine 16 thymoglobulin 14 Vorinostat 14 Calcium Dobesilate 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡